HIFEM uses a strong magnetic field to force intense muscle contractions in short in-office sessions. The clearest signal is easing urinary leakage from the seated pelvic-floor version; muscle and fat changes look small and may be temporary. Most studies were maker-funded, and its value for preserving muscle into older age stays unproven. (Full Review)

Protocol

Body-Contouring Course

4 × 30-min sessions over 2 weeks

Twice weekly, intensity ramped toward 100% as tolerated; some protocols extend to 3–8 sessions.

Pelvic-Floor Course (Seated Device)

6 × 28-min sessions over ~3 weeks

Roughly twice weekly, fully clothed and seated, with periodic maintenance thereafter.

Maintenance

Sessions every 3–6 months

Commonly offered to sustain results, since any muscle or fat change is not self-sustaining.

Time to effect

Pelvic-Floor Symptoms

Over treatment course and weeks after

Symptom improvements generally evaluated across the multi-week course.

Muscle & Fat Changes

End of course; follow-up ~1–3 months

Meaningful, measurable changes typically assessed at course end and later follow-up.

Immediate Firmness

Right after a session

Some users report immediate post-session muscle firmness from swelling.

Benefits

Medium: Reduced stress urinary incontinence; increased abdominal muscle thickness

Low: Reduced subcutaneous fat thickness; improved female sexual function; reduced abdominal muscle separation

Speculative: Preservation of muscle mass for longevity; improved musculoskeletal function and strength

Contraindications

Pregnancy

Cardiac pacemakers, implantable defibrillators

Neurostimulators, implanted drug-delivery pumps

Metal implants or intrauterine devices in/near the treatment field

Active hernia, recent surgery (<6–8 weeks) in the area, malignancy in the field, epilepsy

Key Interactions

Anticoagulants (warfarin, apixaban)

Bleeding disorders

Risk & Side Effects

Medium: Harm from magnetic interaction with implanted devices or metal

Low: Transient muscle soreness and fatigue; transient local skin effects

Speculative: Unknown long-term effects and overstated durability; caution in pregnancy and active pelvic or abdominal pathology

Monitoring

Marker	Target	Why
Body fat percentage	Men 10–20%, women 18–28% (functional target)	Tracks whether overlying fat is masking muscle results and guides realistic expectations
Creatine kinase (CK)	~30–150 U/L	Reflects muscle stress; markedly elevated levels would flag excessive muscle breakdown after very intense sessions
Post-void residual urine	<50–100 mL	For pelvic-floor use, confirms bladder emptying is adequate and helps interpret continence response

Cadence: Baseline before first session; at end of course and follow-up ~1–3 months later; then before any maintenance course (every 3–6 months).

Qualitative Assessment

Reduction in urinary leakage episodes and pad use (for the pelvic-floor application)
Subjective firmness, tone, or strength in the treated muscle group
Improvement in incontinence-related quality of life and confidence
Sexual-function and pelvic-comfort improvements where relevant
Absence of persistent soreness or adverse skin effects between sessions

HIFEM Therapy for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment